Non-opioid Pain Patch Market Size, Share, Growth, and Industry Analysis, By Types (Lidocaine Patches, Diclofenac Patches, Indomethacin Patches, Counter-Irritant Patches, Fentanyl Patches, Others) , Applications (OTC, Rx) and Regional Insights and Forecast to 2034

Detailed TOC of Global Non-opioid Pain Patch Market Insights, Forecast to 2034

1 Study Coverage
1.1 Non-opioid Pain Patch Product Introduction
1.2 Market by Type
1.2.1 Global Non-opioid Pain Patch Market Size Growth Rate by Type, 2020 VS 2022 VS 2033
1.2.2 Lidocaine Patches
1.2.3 Diclofenac Patches
1.2.4 Indomethacin Patches
1.2.5 Counter-Irritant Patches
1.2.6 Fentanyl Patches
1.2.7 Others
1.3 Market by Application
1.3.1 Global Non-opioid Pain Patch Market Size Growth Rate by Application, 2020 VS 2022 VS 2033
1.3.2 OTC
1.3.3 Rx
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Non-opioid Pain Patch Sales Estimates and Forecasts 2020-2033
2.2 Global Non-opioid Pain Patch Revenue by Region
2.2.1 Global Non-opioid Pain Patch Revenue by Region: 2020 VS 2022 VS 2033
2.2.2 Global Non-opioid Pain Patch Revenue by Region (2020-2023)
2.2.3 Global Non-opioid Pain Patch Revenue by Region (2025-2033)
2.2.4 Global Non-opioid Pain Patch Revenue Market Share by Region (2020-2033)
2.3 Global Non-opioid Pain Patch Sales Estimates and Forecasts 2020-2033
2.4 Global Non-opioid Pain Patch Sales by Region
2.4.1 Global Non-opioid Pain Patch Sales by Region: 2020 VS 2022 VS 2033
2.4.2 Global Non-opioid Pain Patch Sales by Region (2020-2023)
2.4.3 Global Non-opioid Pain Patch Sales by Region (2025-2033)
2.4.4 Global Non-opioid Pain Patch Sales Market Share by Region (2020-2033)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Non-opioid Pain Patch Sales by Manufacturers
3.1.1 Global Non-opioid Pain Patch Sales by Manufacturers (2020-2023)
3.1.2 Global Non-opioid Pain Patch Sales Market Share by Manufacturers (2020-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Non-opioid Pain Patch in 2022
3.2 Global Non-opioid Pain Patch Revenue by Manufacturers
3.2.1 Global Non-opioid Pain Patch Revenue by Manufacturers (2020-2023)
3.2.2 Global Non-opioid Pain Patch Revenue Market Share by Manufacturers (2020-2023)
3.2.3 Global Top 10 and Top 5 Companies by Non-opioid Pain Patch Revenue in 2022
3.3 Global Key Players of Non-opioid Pain Patch, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Non-opioid Pain Patch Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Non-opioid Pain Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Non-opioid Pain Patch, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Non-opioid Pain Patch, Product Offered and Application
3.8 Global Key Manufacturers of Non-opioid Pain Patch, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Non-opioid Pain Patch Sales by Type
4.1.1 Global Non-opioid Pain Patch Historical Sales by Type (2020-2023)
4.1.2 Global Non-opioid Pain Patch Forecasted Sales by Type (2025-2033)
4.1.3 Global Non-opioid Pain Patch Sales Market Share by Type (2020-2033)
4.2 Global Non-opioid Pain Patch Revenue by Type
4.2.1 Global Non-opioid Pain Patch Historical Revenue by Type (2020-2023)
4.2.2 Global Non-opioid Pain Patch Forecasted Revenue by Type (2025-2033)
4.2.3 Global Non-opioid Pain Patch Revenue Market Share by Type (2020-2033)
4.3 Global Non-opioid Pain Patch Price by Type
4.3.1 Global Non-opioid Pain Patch Price by Type (2020-2023)
4.3.2 Global Non-opioid Pain Patch Price Forecast by Type (2025-2033)
5 Market Size by Application
5.1 Global Non-opioid Pain Patch Sales by Application
5.1.1 Global Non-opioid Pain Patch Historical Sales by Application (2020-2023)
5.1.2 Global Non-opioid Pain Patch Forecasted Sales by Application (2025-2033)
5.1.3 Global Non-opioid Pain Patch Sales Market Share by Application (2020-2033)
5.2 Global Non-opioid Pain Patch Revenue by Application
5.2.1 Global Non-opioid Pain Patch Historical Revenue by Application (2020-2023)
5.2.2 Global Non-opioid Pain Patch Forecasted Revenue by Application (2025-2033)
5.2.3 Global Non-opioid Pain Patch Revenue Market Share by Application (2020-2033)
5.3 Global Non-opioid Pain Patch Price by Application
5.3.1 Global Non-opioid Pain Patch Price by Application (2020-2023)
5.3.2 Global Non-opioid Pain Patch Price Forecast by Application (2025-2033)
6 US & Canada
6.1 US & Canada Non-opioid Pain Patch Market Size by Type
6.1.1 US & Canada Non-opioid Pain Patch Sales by Type (2020-2033)
6.1.2 US & Canada Non-opioid Pain Patch Revenue by Type (2020-2033)
6.2 US & Canada Non-opioid Pain Patch Market Size by Application
6.2.1 US & Canada Non-opioid Pain Patch Sales by Application (2020-2033)
6.2.2 US & Canada Non-opioid Pain Patch Revenue by Application (2020-2033)
6.3 US & Canada Non-opioid Pain Patch Market Size by Country
6.3.1 US & Canada Non-opioid Pain Patch Revenue by Country: 2020 VS 2022 VS 2033
6.3.2 US & Canada Non-opioid Pain Patch Sales by Country (2020-2033)
6.3.3 US & Canada Non-opioid Pain Patch Revenue by Country (2020-2033)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Non-opioid Pain Patch Market Size by Type
7.1.1 Europe Non-opioid Pain Patch Sales by Type (2020-2033)
7.1.2 Europe Non-opioid Pain Patch Revenue by Type (2020-2033)
7.2 Europe Non-opioid Pain Patch Market Size by Application
7.2.1 Europe Non-opioid Pain Patch Sales by Application (2020-2033)
7.2.2 Europe Non-opioid Pain Patch Revenue by Application (2020-2033)
7.3 Europe Non-opioid Pain Patch Market Size by Country
7.3.1 Europe Non-opioid Pain Patch Revenue by Country: 2020 VS 2022 VS 2033
7.3.2 Europe Non-opioid Pain Patch Sales by Country (2020-2033)
7.3.3 Europe Non-opioid Pain Patch Revenue by Country (2020-2033)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Non-opioid Pain Patch Market Size
8.1.1 China Non-opioid Pain Patch Sales (2020-2033)
8.1.2 China Non-opioid Pain Patch Revenue (2020-2033)
8.2 China Non-opioid Pain Patch Market Size by Application
8.2.1 China Non-opioid Pain Patch Sales by Application (2020-2033)
8.2.2 China Non-opioid Pain Patch Revenue by Application (2020-2033)
9 Asia (excluding China)
9.1 Asia Non-opioid Pain Patch Market Size by Type
9.1.1 Asia Non-opioid Pain Patch Sales by Type (2020-2033)
9.1.2 Asia Non-opioid Pain Patch Revenue by Type (2020-2033)
9.2 Asia Non-opioid Pain Patch Market Size by Application
9.2.1 Asia Non-opioid Pain Patch Sales by Application (2020-2033)
9.2.2 Asia Non-opioid Pain Patch Revenue by Application (2020-2033)
9.3 Asia Non-opioid Pain Patch Sales by Region
9.3.1 Asia Non-opioid Pain Patch Revenue by Region: 2020 VS 2022 VS 2033
9.3.2 Asia Non-opioid Pain Patch Revenue by Region (2020-2033)
9.3.3 Asia Non-opioid Pain Patch Sales by Region (2020-2033)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Non-opioid Pain Patch Market Size by Type
10.1.1 Middle East, Africa and Latin America Non-opioid Pain Patch Sales by Type (2020-2033)
10.1.2 Middle East, Africa and Latin America Non-opioid Pain Patch Revenue by Type (2020-2033)
10.2 Middle East, Africa and Latin America Non-opioid Pain Patch Market Size by Application
10.2.1 Middle East, Africa and Latin America Non-opioid Pain Patch Sales by Application (2020-2033)
10.2.2 Middle East, Africa and Latin America Non-opioid Pain Patch Revenue by Application (2020-2033)
10.3 Middle East, Africa and Latin America Non-opioid Pain Patch Sales by Country
10.3.1 Middle East, Africa and Latin America Non-opioid Pain Patch Revenue by Country: 2020 VS 2022 VS 2033
10.3.2 Middle East, Africa and Latin America Non-opioid Pain Patch Revenue by Country (2020-2033)
10.3.3 Middle East, Africa and Latin America Non-opioid Pain Patch Sales by Country (2020-2033)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Hisamitsu
11.1.1 Hisamitsu Company Information
11.1.2 Hisamitsu Overview
11.1.3 Hisamitsu Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2020-2023)
11.1.4 Hisamitsu Non-opioid Pain Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Hisamitsu Recent Developments
11.2 Mylan
11.2.1 Mylan Company Information
11.2.2 Mylan Overview
11.2.3 Mylan Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2020-2023)
11.2.4 Mylan Non-opioid Pain Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Mylan Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Overview
11.3.3 Johnson & Johnson Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2020-2023)
11.3.4 Johnson & Johnson Non-opioid Pain Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Johnson & Johnson Recent Developments
11.4 Actavis
11.4.1 Actavis Company Information
11.4.2 Actavis Overview
11.4.3 Actavis Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2020-2023)
11.4.4 Actavis Non-opioid Pain Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Actavis Recent Developments
11.5 Lingrui
11.5.1 Lingrui Company Information
11.5.2 Lingrui Overview
11.5.3 Lingrui Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2020-2023)
11.5.4 Lingrui Non-opioid Pain Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Lingrui Recent Developments
11.6 Teikoku Seiyaku
11.6.1 Teikoku Seiyaku Company Information
11.6.2 Teikoku Seiyaku Overview
11.6.3 Teikoku Seiyaku Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2020-2023)
11.6.4 Teikoku Seiyaku Non-opioid Pain Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teikoku Seiyaku Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Overview
11.7.3 Sanofi Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2020-2023)
11.7.4 Sanofi Non-opioid Pain Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sanofi Recent Developments
11.8 Novartis
11.8.1 Novartis Company Information
11.8.2 Novartis Overview
11.8.3 Novartis Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2020-2023)
11.8.4 Novartis Non-opioid Pain Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Novartis Recent Developments
11.9 Qizheng
11.9.1 Qizheng Company Information
11.9.2 Qizheng Overview
11.9.3 Qizheng Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2020-2023)
11.9.4 Qizheng Non-opioid Pain Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Qizheng Recent Developments
11.10 Endo
11.10.1 Endo Company Information
11.10.2 Endo Overview
11.10.3 Endo Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2020-2023)
11.10.4 Endo Non-opioid Pain Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Endo Recent Developments
11.11 Huarun 999
11.11.1 Huarun 999 Company Information
11.11.2 Huarun 999 Overview
11.11.3 Huarun 999 Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2020-2023)
11.11.4 Huarun 999 Non-opioid Pain Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Huarun 999 Recent Developments
11.12 GSK
11.12.1 GSK Company Information
11.12.2 GSK Overview
11.12.3 GSK Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2020-2023)
11.12.4 GSK Non-opioid Pain Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 GSK Recent Developments
11.13 Haw Par
11.13.1 Haw Par Company Information
11.13.2 Haw Par Overview
11.13.3 Haw Par Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2020-2023)
11.13.4 Haw Par Non-opioid Pain Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Haw Par Recent Developments
11.14 Nichiban
11.14.1 Nichiban Company Information
11.14.2 Nichiban Overview
11.14.3 Nichiban Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2020-2023)
11.14.4 Nichiban Non-opioid Pain Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Nichiban Recent Developments
11.15 Mentholatum
11.15.1 Mentholatum Company Information
11.15.2 Mentholatum Overview
11.15.3 Mentholatum Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2020-2023)
11.15.4 Mentholatum Non-opioid Pain Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Mentholatum Recent Developments
11.16 Laboratoires Genevrier
11.16.1 Laboratoires Genevrier Company Information
11.16.2 Laboratoires Genevrier Overview
11.16.3 Laboratoires Genevrier Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2020-2023)
11.16.4 Laboratoires Genevrier Non-opioid Pain Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Laboratoires Genevrier Recent Developments
11.17 BLUE-EMU
11.17.1 BLUE-EMU Company Information
11.17.2 BLUE-EMU Overview
11.17.3 BLUE-EMU Non-opioid Pain Patch Sales, Price, Revenue and Gross Margin (2020-2023)
11.17.4 BLUE-EMU Non-opioid Pain Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 BLUE-EMU Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Non-opioid Pain Patch Industry Chain Analysis
12.2 Non-opioid Pain Patch Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Non-opioid Pain Patch Production Mode & Process
12.4 Non-opioid Pain Patch Sales and Marketing
12.4.1 Non-opioid Pain Patch Sales Channels
12.4.2 Non-opioid Pain Patch Distributors
12.5 Non-opioid Pain Patch Customers
13 Market Dynamics
13.1 Non-opioid Pain Patch Industry Trends
13.2 Non-opioid Pain Patch Market Drivers
13.3 Non-opioid Pain Patch Market Challenges
13.4 Non-opioid Pain Patch Market Restraints
14 Key Findings in The Global Non-opioid Pain Patch Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer